RICHARD KOPPES
CIK 1201944 · last filed 2013-04-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.1K
Companies
2
Total Filings
25
Lifetime Open-Market Net
-$244.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Director | 0 | — | — | $24.0K | 15 | 2010-09-30 |
| AHG | Director | 9,067 | $1.33 | $12.1K | -$268.6K | 2 | 2008-06-06 |
Recent Filings · Page 2 of 3
25 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-05 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +180 | $0 | EDGAR |
| 2010-01-05 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +247 | $0 | EDGAR |
| 2009-10-05 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +289 | $0 | EDGAR |
| 2009-07-01 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +302 | $0 | EDGAR |
| 2009-05-13 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +6,660 | $0 | EDGAR |
| 2009-04-02 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +210 | $0 | EDGAR |
| 2009-04-01 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +151 | $0 | EDGAR |
| 2009-03-09 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,500 | $24.0K | EDGAR |
| 2009-03-03 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +46 | $0 | EDGAR |
| 2009-01-06 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +163 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.